6505--PET Prostate-Specific Membrane Antigen Radiopharmaceuticals Amend for Questions and Answers

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

252-NETWORK CONTRACT OFFICE 12 (36C252)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C25226Q0211

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

Chicago, Illinois, UNITED STATES

SourceSAM
Documents4
The Department of Veterans Affairs, through its 252-Network Contract Office 12, has issued a combined synopsis/solicitation (Procurement Identifier: 36C25226Q0211) for the provision of PET Prostate-Specific Membrane Antigen (PSMA) radiopharmaceuticals. This procurement is intended to support diagnostic imaging services for veterans at the VA facility located in Chicago, Illinois. The primary objective of this solicitation is to secure a reliable supply of FDA-approved PSMA radiopharmaceuticals used in PET imaging for prostate cancer diagnostics. The products specified include, but are not limited to, fluciclovine F 18 (Axumin), gallium-68 PSMA-11 (Illuccix, Locametz), piflufolastat F 18 (Pylarify), and flotufolastat F 18 (Posluma). The successful contractor will be responsible for the timely and consistent delivery of these agents to meet the clinical needs of the VA’s patient population. A key requirement of this procurement is the contractor’s obligation to provide comprehensive contingency plans prior to award. This includes establishing alternative sourcing strategies to ensure uninterrupted supply in the event that local radiopharmacies are unable to fulfill routine deliveries. The contractor must assume full responsibility and accountability for these contingency measures, thereby safeguarding the continuity of patient care. Scheduling flexibility is another critical aspect of this contract. While most orders will be placed in advance as part of routine scheduling, the contractor must also accommodate same-day orders for afternoon deliveries. In such cases, orders will be submitted before 10:00 AM (or another mutually agreed-upon cut-off time) to allow for adequate dose preparation and delivery logistics. This solicitation is not a sole source request; multiple FDA-approved PSMA products are acceptable, and competition is encouraged. The procurement is classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing), with a Product Service Code of 6505, indicating a focus on pharmaceutical products. The place of performance for this contract is Chicago, Illinois. The opportunity is open to qualified vendors capable of meeting the outlined requirements and delivering high-quality radiopharmaceuticals in accordance with VA standards. Interested parties should note that the notice is active, with a response deadline of January 26, 2026. The primary point of contact for this solicitation is Stacy Massey, who can be reached at [email protected] or by phone at 414-844-8400. Additional details, including attachments, can be accessed via the official SAM.gov opportunity listing at https://sam.gov/opp/79d0e5ccd8604afc894314ea0311fa7e/view. Contractors considering this opportunity should ensure they have the capacity to provide the specified radiopharmaceuticals, maintain robust contingency planning, and offer flexible, reliable delivery services to support the VA’s diagnostic imaging needs throughout the contract lifecycle.